Literature DB >> 17152923

Association of ceramides in human plasma with risk factors of atherosclerosis.

Ikuyo Ichi1, Kayoko Nakahara, Yayoi Miyashita, Atsuko Hidaka, Sahoko Kutsukake, Kana Inoue, Taro Maruyama, Yoshikazu Miwa, Mariko Harada-Shiba, Motoo Tsushima, Shosuke Kojo.   

Abstract

Atherosclerosis is a multifactorial disorder. Recent studies indicate that the plasma level of sphingomyelin, which yields ceramide, correlates with the risk of coronary heart disease. Therefore, ceramide, a well-known lipid causing apoptosis in various cell types, may contribute to atherogenesis. We examined the relationship between ceramide concentration and risk factors of atherosclerosis in normal human plasma using electrospray tandem mass spectrometry (LC-MS/MS). Major ceramides in human plasma were C24:0 and C24:1. The ceramide concentration showed a significant positive correlation with total cholesterol (TC) and triglycerides (TG). In addition, plasma ceramide level increased drastically at a high level of LDL cholesterol (more than 170 mg/dL). Our previous studies demonstrated that the sum of fragmented and conjugated apolipoprotein B-100 proteins (B-ox), which were products of a radical reaction of LDL as well as plasma, was a reliable index of atherosclerosis. B-ox showed a significant positive correlation with the plasma ceramide level. Based on these results, we propose that the ceramide level in human plasma is a risk factor at the early stages of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17152923     DOI: 10.1007/s11745-006-5041-6

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.646


  45 in total

Review 1.  De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway.

Authors:  Alfred H Merrill
Journal:  J Biol Chem       Date:  2002-05-13       Impact factor: 5.157

Review 2.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

3.  Unusually high reactivity of apolipoprotein B-100 among proteins to radical reactions induced in human plasma.

Authors:  R Hashimoto; S Narita; Y Yamada; K Tanaka; S Kojo
Journal:  Biochim Biophys Acta       Date:  2000-01-17

4.  The involvement of low-density lipoprotein in hemin transport potentiates peroxidative damage.

Authors:  Y I Miller; Y Felikman; N Shaklai
Journal:  Biochim Biophys Acta       Date:  1995-10-17

5.  Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions.

Authors:  A Matsumoto; M Naito; H Itakura; S Ikemoto; H Asaoka; I Hayakawa; H Kanamori; H Aburatani; F Takaku; H Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

Review 6.  Vitamin C: basic metabolism and its function as an index of oxidative stress.

Authors:  Shosuke Kojo
Journal:  Curr Med Chem       Date:  2004-04       Impact factor: 4.530

7.  Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.

Authors:  Nathalie Augé; Françoise Maupas-Schwalm; Meyer Elbaz; Jean-Claude Thiers; Axel Waysbort; Shigeyoshi Itohara; Hans-Willi Krell; Robert Salvayre; Anne Nègre-Salvayre
Journal:  Circulation       Date:  2004-07-26       Impact factor: 29.690

8.  Sphingomyelinase enhances low density lipoprotein uptake and ability to induce cholesteryl ester accumulation in macrophages.

Authors:  X X Xu; I Tabas
Journal:  J Biol Chem       Date:  1991-12-25       Impact factor: 5.157

9.  Differential distribution of sphingomyelins among plasma lipoprotein classes.

Authors:  J J Myher; A Kuksis; W C Breckenridge; J A Little
Journal:  Can J Biochem       Date:  1981-08

10.  Lipoprotein lipase and sphingomyelinase synergistically enhance the association of atherogenic lipoproteins with smooth muscle cells and extracellular matrix. A possible mechanism for low density lipoprotein and lipoprotein(a) retention and macrophage foam cell formation.

Authors:  I Tabas; Y Li; R W Brocia; S W Xu; T L Swenson; K J Williams
Journal:  J Biol Chem       Date:  1993-09-25       Impact factor: 5.157

View more
  48 in total

Review 1.  Oxidized LDL: diversity, patterns of recognition, and pathophysiology.

Authors:  Irena Levitan; Suncica Volkov; Papasani V Subbaiah
Journal:  Antioxid Redox Signal       Date:  2010-07-01       Impact factor: 8.401

2.  A Lipidomics Approach to Assess the Association Between Plasma Sphingolipids and Verbal Memory Performance in Coronary Artery Disease Patients Undertaking Cardiac Rehabilitation: A C18:0 Signature for Cognitive Response to Exercise.

Authors:  Mahwesh Saleem; Nathan Herrmann; Adam Dinoff; Michelle M Mielke; Paul I Oh; Prathiba Shammi; Xingshan Cao; Swarajya Lakshmi Vattem Venkata; Norman J Haughey; Krista L Lanctôt
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

3.  Lipidomics reveals a remarkable diversity of lipids in human plasma.

Authors:  Oswald Quehenberger; Aaron M Armando; Alex H Brown; Stephen B Milne; David S Myers; Alfred H Merrill; Sibali Bandyopadhyay; Kristin N Jones; Samuel Kelly; Rebecca L Shaner; Cameron M Sullards; Elaine Wang; Robert C Murphy; Robert M Barkley; Thomas J Leiker; Christian R H Raetz; Ziqiang Guan; Gregory M Laird; David A Six; David W Russell; Jeffrey G McDonald; Shankar Subramaniam; Eoin Fahy; Edward A Dennis
Journal:  J Lipid Res       Date:  2010-07-29       Impact factor: 5.922

4.  Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II.

Authors:  Michelle M Mielke; Veera Vankata Ratnam Bandaru; Norman J Haughey; Jin Xia; Linda P Fried; Sevil Yasar; Marilyn Albert; Vijay Varma; Greg Harris; Eric B Schneider; Peter V Rabins; Karen Bandeen-Roche; Constantine G Lyketsos; Michelle C Carlson
Journal:  Neurology       Date:  2012-07-18       Impact factor: 9.910

5.  Ceramide changes the mediator of flow-induced vasodilation from nitric oxide to hydrogen peroxide in the human microcirculation.

Authors:  Julie K Freed; Andreas M Beyer; John A LoGiudice; Joseph C Hockenberry; David D Gutterman
Journal:  Circ Res       Date:  2014-06-11       Impact factor: 17.367

Review 6.  Alterations of the sphingolipid pathway in Alzheimer's disease: new biomarkers and treatment targets?

Authors:  Michelle M Mielke; Constantine G Lyketsos
Journal:  Neuromolecular Med       Date:  2010-06-23       Impact factor: 3.843

7.  Quantification of ceramide species in biological samples by liquid chromatography electrospray ionization tandem mass spectrometry.

Authors:  Takhar Kasumov; Hazel Huang; Yoon-Mi Chung; Renliang Zhang; Arthur J McCullough; John P Kirwan
Journal:  Anal Biochem       Date:  2010-02-21       Impact factor: 3.365

8.  Serum sphingomyelins and ceramides are early predictors of memory impairment.

Authors:  Michelle M Mielke; Veera Venkata Ratnam Bandaru; Norman J Haughey; Peter V Rabins; Constantine G Lyketsos; Michelle C Carlson
Journal:  Neurobiol Aging       Date:  2008-05-05       Impact factor: 4.673

9.  Plasma lipid profiling in a large population-based cohort.

Authors:  Jacquelyn M Weir; Gerard Wong; Christopher K Barlow; Melissa A Greeve; Adam Kowalczyk; Laura Almasy; Anthony G Comuzzie; Michael C Mahaney; Jeremy B M Jowett; Jonathan Shaw; Joanne E Curran; John Blangero; Peter J Meikle
Journal:  J Lipid Res       Date:  2013-07-18       Impact factor: 5.922

10.  Could plasma sphingolipids be diagnostic or prognostic biomarkers for Alzheimer's disease?

Authors:  Michelle M Mielke; Norman J Haughey
Journal:  Clin Lipidol       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.